Balrampur Chini ₹450 Cr Fundraise to Back PLA Capex 2026

What the board approved and why it matters

Balrampur Chini Mills Limited has outlined a funding and capex plan that pushes it further beyond sugar and ethanol. The company announced a ₹450 crore fundraise through a preferential issue of equity shares to promoters and institutional investors. At the same time, it revised the capital outlay for its Poly Lactic Acid (PLA) project and cleared a new gypsum processing plant in Uttar Pradesh.

The stated objective across these moves is revenue diversification and greater value capture from by-products. The company’s updates were disclosed through exchange communication, with BSE cited as the source.

Preferential issue: size, pricing, and participants

The Board of Directors approved the issuance of up to 93,16,771 equity shares at ₹483 per share. The total issue size is ₹450 crore. Participation includes promoters and institutional investors, with names referenced such as TATA Small Cap Fund and various alternative investment funds.

Preferential allotments are typically executed after shareholder approval and other regulatory processes. In this case, the company has already laid out a timeline for shareholder consideration.

Shareholder vote: EGM scheduled for May 20, 2026

Balrampur Chini Mills has scheduled an Extraordinary General Meeting (EGM) for May 20, 2026. The purpose is to seek final shareholder approval for the preferential issue. The company also disclosed a board meeting intimation indicating that a meeting of the Board of Directors was scheduled on 23/04/2026, including consideration of the fundraise proposal.

For investors, the EGM date is a key marker because it is the formal step required before capital can be infused through the proposed equity issuance.

PLA project capex revised to ₹3,080 crore

The company revised the estimated capital outlay for its 80,000 tonnes per annum PLA project from ₹2,850 crore to ₹3,080 crore. The increase is ₹230 crore. The company attributed the higher estimate to rising costs in construction materials and supply chain adjustments.

Balrampur Chini has previously communicated that its PLA project is a core long-term initiative. The company has also indicated, in other disclosed context, that the PLA project was over 75% complete and was on track for a Q3 FY27 launch, with production expected to commence by the third quarter of FY27.

How the company plans to fund the PLA build-out

Balrampur Chini stated that the increased PLA expenditure will be covered through a mix of the new equity issue, debt financing, and internal cash accruals. This indicates that the preferential issue is positioned as one part of a broader capital plan rather than a standalone funding solution.

Separately, the company has described its strategy as using cash flows from sugar and ethanol to support the transition into bio-plastics. The PLA segment has also been identified as a separate reportable segment in the company’s disclosures.

New lactogypsum plant at Kumbhi: ₹160 crore investment

Alongside PLA, the company approved a Lactogypsum Processing Plant at its Kumbhi facility in Uttar Pradesh. The estimated cost is ₹160 crore. The plant is planned with an annual capacity of 76 lakh gypsum boards.

The gypsum initiative is framed as an operational efficiency and by-product monetisation step. For a sugar-ethanol company adding newer chemical and material streams, this type of project can improve value recovery from the broader manufacturing chain, based on what the company has communicated.

Debt option: up to ₹200 crore via listed, secured NCDs

Beyond the equity route, the board approved the issuance of listed, secured, non-convertible debentures (NCDs) on a private placement basis. The company plans to raise up to ₹200 crore in one or more tranches. It described the NCD plan as part of broader financial objectives and as a measure to strengthen its capital structure.

This adds a second funding lever alongside the preferential issue, and aligns with the company’s stated approach of combining equity, debt, and internal accruals.

Policy and operating backdrop referenced by the company

In earlier disclosed commentary around the PLA push, the company referenced support from the Uttar Pradesh Bio-Plastic Policy. The disclosures mentioned a 50% capital subsidy and a 10-year SGST reimbursement.

The company has also flagged cost pressures linked to cane pricing. In Uttar Pradesh, it referenced a 30 rupee increase in cane price, and raised the importance of MSP alignment with cost structures for timely payments to farmers.

Market snapshot and visible investor cues

In a separate market update referenced in the provided text, Balrampur Chini shares were reported trading over 1% higher at ₹461.75 on the NSE in afternoon trade on February 23. Other market data points in the text include: a last traded price of ₹471.85 after the stock moved up 4.06% from a previous close of ₹453.45, and a share price of ₹469.25 as of 10 Feb, 2026.

The same dataset also lists EPS (TTM) at ₹20.06 and market capitalisation at ₹9,188.74 crore, alongside other market ratios.

Key facts at a glance

Why this combination of equity, debt, and capex is being watched

The package of decisions ties capital raising directly to a shift in business mix. The preferential issue and the proposed NCDs together broaden the company’s funding toolkit at a time when its headline growth project has become more expensive.

The PLA capex revision also provides a clearer, updated cost benchmark for investors tracking execution risk and funding needs. And the gypsum processing project adds a second, smaller but measurable capex line tied to by-product monetisation, which the company has highlighted as part of its value enhancement approach.

Conclusion

Balrampur Chini Mills has set a near-term corporate action calendar around its ₹450 crore preferential issue, with the shareholder vote scheduled for May 20, 2026. The proceeds, along with debt and internal accruals, are positioned to support the revised ₹3,080 crore PLA project and the ₹160 crore lactogypsum processing plant at Kumbhi. The next formal milestone for investors is the outcome of the EGM and subsequent steps on the equity allotment and NCD tranches, as applicable.